Cargando…

Clinical Profile of Cyclooxygenase-2 Inhibitors in Treating Non-Small Cell Lung Cancer: A Meta-Analysis of Nine Randomized Clinical Trials

BACKGROUND: Evidence on the benefits of combining cyclooxygenase-2 inhibitor (COX-2) in treating non-small cell lung cancer (NSCLC) is still controversial. We investigated the efficacy and safety profile of cyclooxygenase-2 inhibitors in treating NSCLC. METHODS: The first meta-analysis of eligible s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yuan Yuan, Hu, Zhi Gang, Zeng, Fan Jun, Han, Jiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805232/ https://www.ncbi.nlm.nih.gov/pubmed/27007231 http://dx.doi.org/10.1371/journal.pone.0151939

Ejemplares similares

Pooled analysis of the clinical benefit of cyclooxygenase-2 inhibitors combined with chemotherapy in advanced non-small cell lung cancer
por: Zheng, Wei, et al.
Publicado: (2019)

Effect of cyclooxygenase inhibitor use on immunotherapy efficacy in non‐small cell lung cancer
por: Kanai, Osamu, et al.
Publicado: (2021)

Clinical Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer Patients with Liver Metastases: A Network Meta-Analysis of Nine Randomized Controlled Trials
por: Yin, Qing, et al.
Publicado: (2022)

Histological transformation of non-small cell lung cancer: Clinical analysis of nine cases
por: Jin, Cai-Bao, et al.
Publicado: (2021)

Analysis of lung transcriptome in calves infected with Bovine Respiratory Syncytial Virus and treated with antiviral and/or cyclooxygenase inhibitor
por: Lebedev, Maxim, et al.
Publicado: (2021)

Prevention of Severe Acute Pancreatitis With Cyclooxygenase-2 Inhibitors: A Randomized Controlled Clinical Trial
por: Huang, Zhiyin, et al.
Publicado: (2020)

Cannabinoid system and cyclooxygenases inhibitors
por: Păunescu, H, et al.
Publicado: (2011)

Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2
por: Park, Won, et al.
Publicado: (2008)

Expression and clinical significance of cyclooxygenase 2 and survivin in human gliomas
por: Zhang, Fan, et al.
Publicado: (2017)

Complete response associated with immune checkpoint inhibitors in advanced non-small-cell lung cancer: a meta-analysis of nine randomized controlled trials
por: Li, Jie, et al.
Publicado: (2019)

Intravascular ultrasound versus angiography-guided drug-eluting stent implantation in patients with complex coronary lesions: An updated meta-analysis of nine randomized clinical trials
por: Fan, Zhong-Guo, et al.
Publicado: (2019)

Cyclooxygenase-2 inhibitors: promise or peril?
por: Mengle-Gaw, Laurel J, et al.
Publicado: (2002)

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
por: Smith, Francine G., et al.
Publicado: (2012)

Colorectal Carcinoma, Cyclooxygenases, and COX Inhibitors
por: Ganduri, Vinutna, et al.
Publicado: (2022)

Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo
por: Li, Wei, et al.
Publicado: (2011)

Meta-analysis of overall incidence and risk of ALK inhibitors-induced liver toxicities in advanced non-small-cell lung cancer
por: Li, Jingjie, et al.
Publicado: (2019)

Prognostic and Clinical Significance of Cyclooxygenase-2 Overexpression in Endometrial Cancer: A Meta-Analysis
por: Li, Mingli, et al.
Publicado: (2020)

Fetal Meconium Peritonitis: A Clinical Study of Nine Cases
por: Fu, Fengping, et al.
Publicado: (2022)

Vascular endothelial growth factor promotes the expression of cyclooxygenase 2 and matrix metalloproteinases in Lewis lung carcinoma cells
por: HU, JIANWU, et al.
Publicado: (2012)

Clinical analysis of small cell carcinoma of the bladder in Chinese: nine case reports and literature reviews
por: Chen, Zhi, et al.
Publicado: (2017)

Antimetastatic activity of a cyclooxygenase-2 inhibitor
por: Roche-Nagle, G, et al.
Publicado: (2004)

Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors
por: Tabrizchi, Reza
Publicado: (2006)

Celecoxib: a selective cyclooxygenase-2 inhibitor
por: Gandelman, M
Publicado: (2003)

Effects of Cyclooxygenase Inhibitors on Apoptotic Neuroretinal Cells
por: Brust, Anja-Kristina, et al.
Publicado: (2008)

Renal Effects of Prostaglandins and Cyclooxygenase-2 Inhibitors
por: Kim, Gheun-Ho
Publicado: (2008)

Antiproliferative Benzoindazolequinones as Potential Cyclooxygenase-2 Inhibitors
por: Molinari, Aurora, et al.
Publicado: (2019)

Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
por: Curtis, Elizabeth, et al.
Publicado: (2019)

Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors
por: Bai, Yongkang, et al.
Publicado: (2023)

Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy
por: Shimizu, Katsuhiko, et al.
Publicado: (2015)

Discovery of Novel Pyridazine-Based Cyclooxygenase-2 Inhibitors with a Promising Gastric Safety Profile
por: Khan, Abida, et al.
Publicado: (2020)

Clinical Efficacy of Immune Checkpoint Inhibitors in Older Non-small-Cell Lung Cancer Patients: A Meta-Analysis
por: Sun, You-Meng, et al.
Publicado: (2020)

The cyclooxygenases
por: Chandrasekharan, NV, et al.
Publicado: (2004)

Cyclooxygenase-1-selective inhibitor SC-560
por: Long, Sihui, et al.
Publicado: (2009)

Stimulatory Action of Cyclooxygenase Inhibitors on Hematopoiesis: A Review
por: Hofer, Michal, et al.
Publicado: (2012)

In situ click chemistry generation of cyclooxygenase-2 inhibitors
por: Bhardwaj, Atul, et al.
Publicado: (2017)

Aspirin-triggered 15-epi-lipoxin A(4) predicts cyclooxygenase-2 in the lungs of LPS-treated mice but not in the circulation: implications for a clinical test
por: Kirkby, Nicholas S., et al.
Publicado: (2013)

RNA profiling of cyclooxygenases 1 and 2 in colorectal cancer
por: Church, R D, et al.
Publicado: (2004)

Clinical analysis of sixty-nine children with anomalous aortic origin of the coronary artery
por: Zhen, Zhen, et al.
Publicado: (2023)

Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials
por: Bornstein, Natan M., et al.
Publicado: (2017)

Association and clinical implication of the USP10 and MSH2 proteins in non-small cell lung cancer
por: Zeng, Zhi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q40bm496qcp908tmaghsmj590f